Cite Filings / GALT / 0001140361-25-042116
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
10-Q

Quarterly Report

GALECTIN THERAPEUTICS INC · Filed 2025-11-14 · Acc 0001140361-25-042116

Documents 1

  • 10-Q Quarterly Report , ef20054993_10q.htm

Around this filing

  • 2026-05-15 10-Q Quarterly Report
  • 2025-11-14 8-K Results of operations
  • 2025-11-14 10-Q Quarterly Report
  • 2025-11-14 4 Chief Medical Officer sold 121,117 shares at $5.47 ($662,510)
  • 2025-11-13 144 Sale of Securities
  • 2025-11-12 4 10% owner sold 40,000 shares at $5.25 ($210,000)
  • 2025-08-14 10-Q Quarterly Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading ef20054993_10q.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…